Program Management for GMP Manufacturing for Spray-Dried Biologics Facility Build
Global biotechnology company in need of program management support for the design, construction, and qualification…
Kymanox Announces the Appointment of Evan Edwards to Chief Executive Officer and the Transition of Stephen M. Perry to Executive Chairman
Planned Leadership Transition Positions Kymanox for Continued Growth and Innovation
How to Build a Scalable QMS from Clinic to Commercial
Practical roadmap for life sciences companies seeking to scale their Quality Management Systems alongside product…
FDA QMSR Alignment to ISO 13485: Key Changes Ahead
While the industry has been anticipating alignment with ISO 13485 for years, the final rule…
Introduction to ISO 23908
Ensure your device or combination product complies with the recent revisions to the Sharps Injury…
How Nose-to-Brain Delivery Is Revolutionizing CNS Therapeutics
Learn how N2B devices, formulations, and FDA precedents are transforming CNS therapeutics.
Kymanox is a Leader in Life Sciences
If you need more information navigate to our Insights page or send us a message.